AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
AdaptHealth Corp.NASDAQ: AHCO
Free Cash Flow · Q1 FY2026 · quarter ended Apr 2026
Free cash flow growth accelerates
Q1 FY2026 free cash flow of $27.49M (cash outflow) rose 47296.6% year over year, ahead of the -30.1% change in trailing-twelve-month free cash flow.
Context
- Free cash flow amounted to 6.8% of revenue in FY2025, down 0.5 pp from a year earlier.
- Free cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +47296.6% holds above the trailing-twelve-month pace of -30.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 219.38M USD
- Year-over-year change
- -7.0%
- 4-year CAGR
- +32.0%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 219.38M | -7.0% |
| FY2024 | 2024-12-31 | 235.78M | +64.7% |
| FY2023 | 2023-12-31 | 143.2M | +915.7% |
| FY2022 | 2022-12-31 | (17.56M) | -124.3% |
| FY2021 | 2021-12-31 | 72.37M | — |
Free Cash Flow vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's LTM Apr 2026 free cash flow of $191.95M is the 2nd largest of the 9 companies compared; the peer median is $15.26M.
- Its year-over-year change of -30.1% is the 8th highest of 9, against a peer median of +20.3%.
- Free cash flow amounts to 6.7% of revenue for AHCO, versus a peer median of 13.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.89B | +74.2% | +43.4% | 51.1% | |
| LTM Apr 2026 | $191.95M | -30.1% | — | 6.7% | |
| LTM Jun 2026 | $117.09M | +37.7% | +216.6% | 13.0% | |
| LTM Mar 2026 | $61.12M | +2.9% | -2.7% | 55.4% | |
| LTM Mar 2026 | $25.92M | +500.0% | +35.0% | 9.0% | |
| LTM Mar 2026 | $20.3M | +57.7% | +113.8% | 14.3% | |
| LTM Mar 2026 | $10.24M | -51.5% | -28.4% | 2.9% | |
| LTM Mar 2026 | $10.23M | -14.4% | — | 14.3% | |
| LTM Mar 2026 | $3.64M | -4.1% | — | 0.4% | |
| Peer median (excluding AHCO) | $15.26M | +20.3% | +39.2% | 13.6% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 158.15M | 73.13M | (678.9M) | 94.78M | (66.04M) |
| Depreciation & Amortization | 258.05M | 351.18M | 420.59M | 365.33M | 381.93M |
| Deferred Income Tax | 22.38M | 18.04M | (62.6M) | 32.05M | 47.16M |
| Stock-Based Compensation | 25.32M | 22.4M | 22.47M | 14.88M | 21.88M |
| Change in Working Capital | (153.31M) | (108M) | (25.11M) | (26.06M) | 66.58M |
| Accounts Receivables | (29.69M) | (209K) | (28.86M) | (26.22M) | 30.99M |
| Inventory | (14.92M) | (6.3M) | 15.53M | (28.07M) | (11.49M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (108.7M) | (101.49M) | (11.78M) | 28.22M | 47.08M |
| Other Non-Cash Items | (34.92M) | 17.12M | 804.2M | 60.86M | 150.26M |
| Operating Cash Flow | 275.68M | 373.87M | 480.67M | 541.84M | 601.77M |
| Capital Expenditures | (203.31M) | (391.42M) | (337.46M) | (306.06M) | (382.39M) |
| Acquisitions (Net) | (1.62B) | (19.02M) | (19.69M) | (9.54M) | (42.38M) |
| Purchases of Investments | (1.13M) | (731K) | (128K) | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 5.32M | 121.58M |
| Investing Cash Flow | (1.82B) | (411.17M) | (357.28M) | (310.28M) | (303.19M) |
| Debt Repayment | 1.4B | (36.18M) | (51.77M) | (179.87M) | (268.48M) |
| Common Stock Issued | 278.85M | 0 | 0 | 0 | 1.21M |
| Common Stock Repurchased | 0 | (13.99M) | (29.28M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (75.68M) | (15.88M) | (11.48M) | (19.08M) | (34.93M) |
| Financing Cash Flow | 1.6B | (66.05M) | (92.53M) | (198.95M) | (302.19M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 49.67M | (103.36M) | 30.86M | 32.62M | (3.61M) |
| Free Cash Flow | 72.37M | (17.56M) | 143.2M | 235.78M | 219.38M |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.